http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020079403-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1e5935591fc427f1acab094f55f325f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate | 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e11106d4213ff96e7b46b527ce3c5870 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96f75afb4dd40bbfe6881b8c5b67a0a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85b6d940ff2d2be59c2f98963ec2629e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c34e90f11738707b04cab296a423fcf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58b318cb5c2e85e0d46beb23920219eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa0ddb6764cb233bce65d84e85146a04 |
| publicationDate | 2002-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20020079403-A |
| titleOfInvention | Cytotoxic t lymphocyte |
| abstract | (Problem) To provide a technique useful for treating and diagnosing a disease caused by the specific expression of prostate specific membrane antigen in Asians, in particular Japanese, specifically cancer, and more preferably prostate cancer.n n n (Solution) A T cell having the sequence of SEQ ID NO: 1 or 2 or a sequence having a mutation, and which specifically recognizes a cell presenting a complex of the peptide of this sequence and the HLA-A24 molecule on the cell surface. HLA-A24 binding antigen peptides and nucleic acids thereof which induce CTLs with receptors; CTL having this T cell receptor; CTL induction method using this HLA-A24 binding antigen peptide; CLA inducers and cancer suppressors containing HLA-A24 binding antigen peptides; CTL containing cancer inhibitors and CTL sensitive cell detectors; Antigen presenting cells presenting this complex; Antigen presenting cell-containing CTL inducers and cancer suppressors; When a change selected from the group consisting of cell lysis, cytokine release and CTL proliferation by CTL occurs by contacting the CTL with a test cell, a method for detecting CTL-sensitive cells as an indicator that the test cell is a CTL-sensitive cell. And detection agents; Detection method of HLA-A24 molecule; Target cells of CTL and a method of manufacturing the same. |
| priorityDate | 2001-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 539.